Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul;20(7):1176-82.
doi: 10.3201/eid2007.131265.

Undiagnosed acute viral febrile illnesses, Sierra Leone

Undiagnosed acute viral febrile illnesses, Sierra Leone

Randal J Schoepp et al. Emerg Infect Dis. 2014 Jul.

Abstract

Sierra Leone in West Africa is in a Lassa fever-hyperendemic region that also includes Guinea and Liberia. Each year, suspected Lassa fever cases result in submission of ≈500-700 samples to the Kenema Government Hospital Lassa Diagnostic Laboratory in eastern Sierra Leone. Generally only 30%-40% of samples tested are positive for Lassa virus (LASV) antigen and/or LASV-specific IgM; thus, 60%-70% of these patients have acute diseases of unknown origin. To investigate what other arthropod-borne and hemorrhagic fever viral diseases might cause serious illness in this region and mimic Lassa fever, we tested patient serum samples that were negative for malaria parasites and LASV. Using IgM-capture ELISAs, we evaluated samples for antibodies to arthropod-borne and other hemorrhagic fever viruses. Approximately 25% of LASV-negative patients had IgM to dengue, West Nile, yellow fever, Rift Valley fever, chikungunya, Ebola, and Marburg viruses but not to Crimean-Congo hemorrhagic fever virus.

Keywords: ELISA; IgM; Lassa virus; Sierra Leone; West Africa; arthropod-borne; diagnostics; febrile; hemorrhagic fever; immunodiagnostics; serologic; undiagnosed; vector-borne infections; viruses.

PubMed Disclaimer

Figures

Figure
Figure
Lassa fever–hyperendemic region (white area) comprising parts of Guinea, Sierra Leone, and Liberia in West Africa. Insert image: Lassa Diagnostic Laboratory, Kenema Government Hospital, Kenema, Sierra Leone.

Similar articles

Cited by

  • Geographic Disparities in Domestic Pig Population Exposure to Ebola Viruses, Guinea, 2017-2019.
    Grayo S, Camara A, Doukouré B, Ellis I, Troupin C, Fischer K, Vanhomwegen J, White M, Groschup MH, Diederich S, Tordo N. Grayo S, et al. Emerg Infect Dis. 2024 Apr;30(4):681-690. doi: 10.3201/eid3004.231034. Emerg Infect Dis. 2024. PMID: 38526081 Free PMC article.
  • Systematic review and meta-analysis of the epidemiology of Lassa virus in humans, rodents and other mammals in sub-Saharan Africa.
    Kenmoe S, Tchatchouang S, Ebogo-Belobo JT, Ka'e AC, Mahamat G, Guiamdjo Simo RE, Bowo-Ngandji A, Demeni Emoh CP, Che E, Tchami Ngongang D, Amougou-Atsama M, Nzukui ND, Mbongue Mikangue CA, Mbaga DS, Kenfack S, Kingue Bebey SR, Amvongo Adjia N, Efietngab AN, Tazokong HR, Modiyinji AF, Kengne-Nde C, Sadeuh-Mba SA, Njouom R. Kenmoe S, et al. PLoS Negl Trop Dis. 2020 Aug 26;14(8):e0008589. doi: 10.1371/journal.pntd.0008589. eCollection 2020 Aug. PLoS Negl Trop Dis. 2020. PMID: 32845889 Free PMC article.
  • Development of Prototype Filovirus Recombinant Antigen Immunoassays.
    Boisen ML, Oottamasathien D, Jones AB, Millett MM, Nelson DS, Bornholdt ZA, Fusco ML, Abelson DM, Oda S, Hartnett JN, Rowland MM, Heinrich ML, Akdag M, Goba A, Momoh M, Fullah M, Baimba F, Gbakie M, Safa S, Fonnie R, Kanneh L, Cross RW, Geisbert JB, Geisbert TW, Kulakosky PC, Grant DS, Shaffer JG, Schieffelin JS, Wilson RB, Saphire EO, Branco LM, Garry RF, Khan SH, Pitts KR; Viral Hemorrhagic Fever Consortium. Boisen ML, et al. J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S359-67. doi: 10.1093/infdis/jiv353. Epub 2015 Jul 30. J Infect Dis. 2015. PMID: 26232440 Free PMC article.
  • Circulating microRNA profiles of Ebola virus infection.
    Duy J, Koehler JW, Honko AN, Schoepp RJ, Wauquier N, Gonzalez JP, Pitt ML, Mucker EM, Johnson JC, O'Hearn A, Bangura J, Coomber M, Minogue TD. Duy J, et al. Sci Rep. 2016 Apr 21;6:24496. doi: 10.1038/srep24496. Sci Rep. 2016. PMID: 27098369 Free PMC article.
  • Epidemiological Investigation of a Rift Valley Fever Outbreak in Humans and Livestock in Kenya, 2018.
    Hassan A, Muturi M, Mwatondo A, Omolo J, Bett B, Gikundi S, Konongoi L, Ofula V, Makayotto L, Kasiti J, Oele E, Onyango C, Gura Z, Njenga K, Munyua P. Hassan A, et al. Am J Trop Med Hyg. 2020 Oct;103(4):1649-1655. doi: 10.4269/ajtmh.20-0387. Am J Trop Med Hyg. 2020. PMID: 32748778 Free PMC article.

References

    1. McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES. A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis. 1987;155:437–44. 10.1093/infdis/155.3.437 - DOI - PubMed
    1. Hadi CM, Goba A, Khan SH, Bangura J, Sankoh M, Koroma S, et al. Ribavirin for Lassa fever postexposure prophylaxis. Emerg Infect Dis. 2010;16:2009–11. 10.3201/eid1612.100994 - DOI - PMC - PubMed
    1. Branco LM, Boisen ML, Andersen KG, Grove JN, Moses LM, Muncy IJ, et al. Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report. [Erratum in: Virol J. 2011;8:480. ]. Virol J. 2011;8:404. 10.1186/1743-422X-8-404 - DOI - PMC - PubMed
    1. Grove JN, Branco LM, Boisen ML, Muncy IJ, Henderson LA, Schieffellin JS, et al. Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report. Virol J. 2011;8:314–27. 10.1186/1743-422X-8-314 - DOI - PMC - PubMed
    1. Branco LM, Grove JN, Boisen ML, Shaffer JG, Goba A, Fullah M, et al. Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection. Virol J. 2011;8:478. 10.1186/1743-422X-8-478 - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources